Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

Potential Iran Deal Impact May Benefit These Markets

BY | ETF Database
10:46 am ET 05/29/26 | 23 VIEWS
  • Related Symbols
  • GEM
While it may have been in the headlines for weeks without conclusion, a U.S.-Iran deal may be actually nearing — for real this time. Markets have been anticipating some kind of arrangement to reopen the Strait of Hormuz for some time. The sheer complexity of the relationships between the U.S., Israel, and Iran has made resolving the war difficult, but if reports are true and a deal is in the offing, some important markets may be poised to benefit.Key Takeaways: Could emerging markets see an outsize benefit from a potential Iran deal? Those nations do often import significant amounts of fuel. Funds like GEM could then be a strong route into emerging markets, if a deal does come to pass. The strategy’s multifactor, proprietary index approach has helped it outperform in recent months. Specifically, emerging markets economies could be standout candidates for a jump, if fuel prices can see a light at the end of the tunnel. Prior to the U.S.-Israel-Iran conflict, investors were flocking to ex-U.S. equities and offerings for their lower valuations and diversification away from the United States.  While that positivity may have been somewhat interrupted by global volatility, a deal would potentially boost emerging markets equities prospects. Many emerging markets rely heavily on imported fuels, making the current closure of fuel shipping out of the Strait a serious headwind. There are plenty of ETFs that investors can consider to get exposure to emerging markets amid that potential upside. Goldman Sachs Asset Management offers funds like GEM and GSEE that do just that. The Goldman Sachs ActiveBeta Emerging Markets Equity ETF (GEM A-) provides a key example. GEM, for example, charges a 35 basis point fee to track a proprietary index. The emerging markets ETF applies a multifactor approach, looking for stocks with momentum, good value, high quality, and low volatility.  That has helped the fund outperform the ETF Database Emerging Markets Equities Category average over all available time frames in ETF Database data. It has outperformed over the last 12 months, three and five years, and as YTD. Specifically, it has returned 51.8% over the last year, compared to the category average of just 38.1%.  See more: Goldman Sachs ETFs Hit $100 Billion AUM The strategy has also seen its price rise above both its 50- and 200-day simple moving averages. That traditionally indicates a buy opportunity as well as healthy momentum. Overall, if an Iran deal is struck to reopen the Strait, emerging markets could be an area that sees notable positivity for the rest of the year, making a fund like GEM one to watch. For more news, information, and strategy, visit the Future ETFs Content Hub.

More Commentary

Moving Beyond Beta: BlackRock Embraces Active International Fixed Income
BY | ETF Database
8:30 am ET 05/29/26 | 29 VIEWS
Muni Bonds Are Back: How BMOP Tackles Summer Opportunities
BY | ETF Database
9:07 am ET 05/29/26 | 10 VIEWS
ProShares Leaders Q&A on Dividend Aristocrat Suite
BY | ETF Database
9:28 am ET 05/29/26 | 5 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.